AMS 700™ inflatable penile prosthesis with InhibiZone®

Expert Review of Medical Devices

Volumn 7, Issue 3, 2010, Pages 311-317

  McKim, Stephen E ^a   Carson III, Culley C ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

AMS 700 ; Biofilm; Erectile dysfunction; InhibiZone ; Penile prosthesis

Indexed keywords

CHLORHEXIDINE; INHIBIZONE; MINOCYCLINE; MINOCYCLINE PLUZ RIFAMPICIN; RIFAMPICIN; SULFADIAZINE SILVER; UNCLASSIFIED DRUG; VANCOMYCIN;

BACTERIAL COLONIZATION; BIOFILM; CANDIDA ALBICANS; CATHETER INFECTION; CLINICAL EFFECTIVENESS; DRUG EFFICACY; DRUG SAFETY; ENTEROCOCCUS FAECALIS; ERECTILE DYSFUNCTION; ESCHERICHIA COLI; HUMAN; INFLATABLE PENILE PROSTHESIS; MATERIAL COATING; NONHUMAN; PATIENT SATISFACTION; PENIS PROSTHESIS; PROSTHESIS INFECTION; PROTEUS MIRABILIS; PSEUDOMONAS AERUGINOSA; REVIEW; SERRATIA MARCESCENS; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS; STENOTROPHOMONAS MALTOPHILIA; SURVIVAL RATE; TREATMENT RESPONSE; ARTICLE; BACTERIUM; DRUG EFFECT; INSTRUMENTATION; MALE; MALE GENITAL SYSTEM SURGERY; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY;

BACTERIA (MICROORGANISMS);

BACTERIA; BIOFILMS; HUMANS; MALE; MICROBIAL SENSITIVITY TESTS; MINOCYCLINE; PENILE IMPLANTATION; PENILE PROSTHESIS; RIFAMPIN;

EID: 77951804453     PISSN: 17434440     EISSN: 17452422     Source Type: Journal    
DOI: 10.1586/erd.10.6     Document Type: Review

References (31)

1. Scott FB, Bradley WE, Timm GW. Management of erectile impotence. Use of implantable infatable prosthesis. Urology 2 (1), 80-82 (1973).
2. Darouiche RO. Treatment of infections associated with surgical implants. N. Engl. J. Med. 350 (14), 1422-1429 (2004). (Pubitemid 38419996)
3. Montorsi F, Rigatti P, Carmignani G et al. AMS three-piece infatable implants for erectile dysfunction: a long-term multiinstitutional study in 200 consecutive patients. Eur. Urol. 37 (1), 50-55 (2000). (Pubitemid 30072374)
4. Levine LA, Estrada CR, Morgentaler A. Mechanical reliability and safety of, and patient satisfaction with the Ambicor infatable penile prosthesis: results of a 2 center study. J. Urol. 166 (3), 932-937 (2001). (Pubitemid 32750986)
5. Mulhall JP, Ahmed A, Branch J, Parker M. Serial assessment of effcacy and satisfaction profles following penile prosthesis surgery. J. Urol. 169 (4), 1429-1433 (2003). (Pubitemid 36323801)
6. Wilson SK, Delk JR, Salem EA, Cleves MA. Long-term survival of infatable penile prostheses: single surgical group experience with 2, 384 frst-time implants spanning two decades. J. Sex. Med. 4 (4 Pt 1), 1074-1079 (2007).
7. Montague DK. Periprosthetic infections. J. Urol. 138 (1), 68-69 (1987).
8. Salem EA, Wilson SK, Neeb A, Delk JR, Cleves MA. Mechanical reliability of AMS 700 CX improved by parylene coating. J. Sex. Med. 6 (9), 2615-2620 (2009).
9. Carson CC, Robertson CN. Late hematogenous infection of penile prostheses. J. Urol. 139 (1), 50-52 (1988).
10. Silverstein A, Donatucci CF. Bacterial bioflms and implantable prosthetic devices. Int. J. Impot. Res. 15 (Suppl. 5), S150-S154 (2003). (Pubitemid 37314348)
11. Silverstein AD, Henry GD, Evans B, Pasmore M, Simmons CJ, Donatucci CF. Bioflm formation on clinically noninfected penile prostheses. J. Urol. 176 (3), 1008-1011 (2006). (Pubitemid 44160709)
12. Thomalla JV, Thompson ST, Rowland RG, Mulcahy JJ. Infectious complications of penile prosthetic implants. J. Urol. 138 (1), 65-67 (1987).
13. Henry GD, Wilson SK, Delk JR 2nd et al. Penile prosthesis cultures during revision surgery: a multicenter study. J. Urol. 172 (1), 153-156 (2004).
14. Darouiche RO, Raad II, Bodey GP, Musher DM. Antibiotic susceptibility of staphylococcal isolates from patients with vascular catheter-related bacteremia: potential role of the combination of minocycline and rifampin. sInt. J. Antimicrob. Agents 6 (1), 31-36 (1995).
15. Raad I, Darouiche R, Hachem R, Sacilowski M, Bodey GP. Antibiotics and prevention of microbial colonization of catheters. Antimicrob. Agents Chemother. 39 (11), 2397-2400 (1995).
16. Raad I, Darouiche R, Hachem R, Mansouri M, Bodey GP. The broadspectrum activity and effcacy of catheters coated with minocycline and rifampin. sJ. Infect. Dis. 173 (2), 418-424 (1996). (Pubitemid 26042443)
17. Raad I, Darouiche R, Dupuis J et al. Central venous catheters coated with minocycline and rifampin for the prevention of catheter-related colonization and bloodstream infections. A randomized, double-blind trial. The Texas Medical Center Catheter Study Group. Ann. Intern. Med. 127 (4), 267-274 (1997). (Pubitemid 27352046)
18. Darouiche RO, Raad II, Heard SO et al. A comparison of two antimicrobialimpregnated central venous catheters. Catheter Study Group. N. Engl. J. Med. 340 (1), 1-8 (1999).
19. Darouiche RO, Hampel OZ, Boone TB, Raad II. Antimicrobial activity and durability of a novel antimicrobialimpregnated bladder catheter. Int. J. Antimicrob. Agents 8 (4), 243-247 (1997).
20. Darouiche RO, Smith JA Jr, Hanna H et al. Effcacy of antimicrobial- impregnated bladder catheters in reducing catheterassociated bacteriuria: a prospective, randomized, multicenter clinical trial. Urology 54 (6), 976-981 (1999).
21. Darouiche RO, Mansouri MD, Raad II. Effcacy of antimicrobial-impregnated silicone sections from penile implants in preventing device colonization in an animal model. Urology 59 (2), 303-307 (2002).
22. Mansouri MD, Boone TB, Darouiche RO. Comparative assessment of antimicrobial activities of antibiotic-treated penile prostheses. Eur. Urol. 56 (6), 1039-1046 (2009).
23. Carson CC. Effcacy of antibiotic impregnation of infatable penile prostheses in decreasing infection in original iimplants. J. Urol. 171 (4), 1611-1614.
24. Erratum in: J. Urol. 172 (2), 781 (2004).
25. Carson CC, Mulcahy JJ, Harsch M. Seven year infection related revision rates for naïve infatable penile prosthesis implants: antibiotic- impregnated vs nonimpregnated. Presented at: Southeastern Section of the American Urological Association Annual Meeting. Miami Beach, Florida, FL, USA, March 11-14 (2010) (Podium Presentation).
26. Droggin D, Shabsigh R, Anastasiadis AG. Antibiotic coating reduces penile prosthesis infection. J. Sex. Med. 2 (4), 565-568 (2005). (Pubitemid 40975842)
27. Abouassaly R, Angermeier K W, Montague DK. Risk of infection with an antibiotic coated penile prosthesis at device replacement for mechanical failure. J. Urol. 176 (6 Pt 1), 2471-2473 (2006). (Pubitemid 44665988)
28. Wilson SK, Zumbe J, Henry GD, Salem EA, Delk JR, Cleves MA. Infection reduction using antibiotic-coated infatable penile prosthesis. Urology 70 (2), 337-340 (2007). (Pubitemid 47362248)
29. Wilson SK, Delk JR 2nd. Infatable penile implant infection: predisposing factors and treatment suggestions. J. Urol. 153 (3 Pt 1), 659-661 (1995).
30. Wilson SK, Carson CC, Cleves MA, Delk JR 2nd. Quantifying risk of penile prosthesis infection with elevated glycosylated hemoglobin. sJ. Urol. 159 (5), 1537-1539 (1998).
31. Wolter CE, Hellstrom WJ. The hydrophilic-coated infatable penile prosthesis: 1-year experience. J. Sex. Med. 1 (2), 221-224 (2004).